Editorial: An Argument for Low-Dose Thiopurine Allopurinol Combination Use as First-Line Therapy in Inflammatory Bowel Disease

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14687
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Editorial: An Argument for Low-Dose Thiopurine Allopurinol Combination Use as First-Line Therapy in Inflammatory Bowel Disease-Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Editorial: Paradoxical Skin Lesions During Anti-TNF Treatment-An Additional Argument to Consider New Biologics as First Line Therapy in Inflammatory Bowel Disease

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Editorial: Paradoxical Skin Lesions During Anti-TNF Treatment-An Additional Argument to Consider New Biologics as First-Line Therapy in Inflammatory Bowel Disease. Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Optimizing Thiopurine Therapy in Inflammatory Bowel Disease Among 2 Real-Life Intercept Cohorts

Inflammatory Bowel Diseases
AllergyImmunologyGastroenterology
2017English

Thiopurine Metabolites and the Role of Thiopurine Methyltransferase Activity in Inflammatory Bowel Disease

Gut
Gastroenterology
2002English

Which Patients With Inflammatory Bowel Disease Should Receive Combination Therapy?

Expert Review of Gastroenterology and Hepatology
HepatologyGastroenterology
2015English

The Utility of Thiopurine Methyltransferase Enzyme Testing in Inflammatory Bowel Disease

Canadian Journal of Gastroenterology
2013English

Editorial: Clinical Benefits of Vitamin D Therapy in Inflammatory Bowel Disease

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Prostaglandins in Inflammatory Bowel Disease Therapy

Canadian Journal of Gastroenterology
1993English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy